Skip to main content
Implementing Accountable Care to Achieve Better Health at a Lower Cost

Implementing Accountable Care to Achieve Better Health at a Lower Cost

Mark McClellan Andrea Thoumi Krishna Udayakumar Hannah Patel Abdul Badi Abou Samra

The goal of accountable care is to ensure that quality care is delivered at a low cost. This report presents the type of policy recommendations that could be used to achieve these desired outcomes.

The Accountable Care Forum will outline the benefits of using an integrated accountable care system to assist patients suffering from chronic diseases, such as diabetes, and who require rigorous, all-encompassing treatment plans. The study will involve a pool of people aged 18 and above diagnosed with type-2 diabetes or pre-diabetes and those at high risk of developing the disease. Conference participants will receive detailed action plans and recommendations, including the process of identifying the cohort; the singling out of individuals within the group suffering from diabetes; a screening plan for the remaining subjects; the development of a care pathway; the establishment of a multidisciplinary team to manage patient care; and individualised healthcare plans and project monitoring.

alt text

Mark McClellan, MD, PhD

Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Policy, and Director of the Duke-Margolis Center for Health Policy at Duke University with offices at Duke and in Washington DC. Dr. McClellan is a doctor and an economist, and his work has addressed a wide range of strategies and policy reforms to improve health care, including payment reforms to promote better outcomes and lower costs, methods for development and use of real-world evidence, and approaches for more effective drug and device innovation. Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. He was also a Senior Fellow at the Brookings Institution and a professor of economics and medicine at Stanford University.